BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Anticoagulant Reversal Drugs Market is predicted to Accelerate the Growth by 2018 - 2026

  Transparency Market Research has published a new report titled, “Anticoagulant Reversal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

  November 16, 2021

   · 

  5 min read
• Orexo announces positive results from pivotal trial for its leading pharmaceutical pipeline asset OX124

  Orexo AB, announces that the company has successfully completed the pivotal trial for its lead pharmaceutical pipeline asset, OX124.

  November 16, 2021

   · 

  5 min read
• Business

  Sonoma Biotherapeutics Appoints Heidi Hagen, MBA as Chief Technical Officer

  Sonoma Biotherapeutics, an immune tolerance company focused on the development of novel regulatory T cell therapies for autoimmune and inflammatory disease, announced the appointment of Heidi Hagen, MBA as Chief Technical Officer.

  November 16, 2021

   · 

  2 min read